About Us / Our History
Our History
About Us / Our History
Our History
Growing with Purpose
Growing with Purpose
Growing with
Purpose
Discover how each chapter has shaped who we are today
Discover how each chapter has shaped who we are today
- 2024
Rebranding
Renamed Sunzen Biotech Berhad to Sunzen Group Berhad in December, symbolizing our growth into a diversified corporate group. - 2024
Entry into Medical sector
Strengthened our footprint in medical devices and services with a 70% acquisition of Eye Nation Medical Sdn Bhd. - 2022
Joint Venture
In partnership with Xmegami Sdn Bhd, Ecolite Biotech Manufacturing Sdn Bhd established Xmegami Manufacturing Sdn Bhd as a joint venture, with a shareholding of 49%. - 2021
Expansion into Financial Services
Ventured into the loan financing sector with the acquisition of Finsource Credit (M) Sdn Bhd. - 2020
Leadership Appointment
Appointed Mr. Teo Yek Ming as Executive Director cum CEO. - 2018
Expansion into TMC
Expanded into Traditional Chinese Medicine (TCM) through the acquisition of Ecolite Biotech Manufacturing Sdn Bhd, initiating our path into diverse health solutions. - 2008
Public Listing
Listed on Bursa Malaysia’s ACE Market on October 8, solidifying our public commitment to growth and transparency. - 2005
Company Establishment
Established Sunzen Biotech Berhad, marking our foray into the biotechnology sector. - 1998
Inception
Establishment of Sunzen Corporation Sdn Bhd
2024
Rebranding
Renamed Sunzen Biotech Berhad to Sunzen Group Berhad in December, symbolizing our growth into a diversified corporate group.2024
Entry into Medical sector
Strengthened our footprint in medical devices and services with a 70% acquisition of Eye Nation Medical Sdn Bhd.2022
Joint Venture
In partnership with Xmegami Sdn Bhd, Ecolite Biotech Manufacturing Sdn Bhd established Xmegami Manufacturing Sdn Bhd as a joint venture, with a shareholding of 49%.2021
Expansion into Financial Services
Ventured into the loan financing sector with the acquisition of Finsource Credit (M) Sdn Bhd.2020
Leadership Appointment
Appointed Mr. Teo Yek Ming as Executive Director cum CEO.2018
Expansion into TMC
Expanded into Traditional Chinese Medicine (TCM) through the acquisition of Ecolite Biotech Manufacturing Sdn Bhd, initiating our path into diverse health solutions.2008
Public Listing
Listed on Bursa Malaysia’s ACE Market on October 8, solidifying our public commitment to growth and transparency.2005
Company Establishment
Established Sunzen Biotech Berhad, marking our foray into the biotechnology sector.1998
